These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 23674179

  • 1. Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe.
    Škamperle M, Kocjan BJ, Maver PJ, Seme K, Poljak M.
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):1-5. PubMed ID: 23674179
    [Abstract] [Full Text] [Related]

  • 2. Global burden of human papillomavirus and related diseases.
    Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population].
    Nahet A, Boublenza L, Hassaine H, Masdoua N, Prétet JL, Belglaiaa E, Mougin C.
    Bull Cancer; 2016 May 20; 103(5):455-60. PubMed ID: 27085765
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.
    Eur J Cancer; 2015 Sep 20; 51(13):1732-41. PubMed ID: 26121913
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
    Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM.
    Obstet Gynecol; 2009 Apr 20; 113(4):917-924. PubMed ID: 19305339
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
    Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N.
    Vaccine; 2009 Jan 29; 27(5):636-9. PubMed ID: 19056450
    [Abstract] [Full Text] [Related]

  • 8. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT, HPV Typing of Cancers Workgroup.
    J Natl Cancer Inst; 2015 Jun 29; 107(6):djv086. PubMed ID: 25925419
    [Abstract] [Full Text] [Related]

  • 9. Investigating a cluster of vulvar cancers in young women: distribution of human papillomavirus and HPV-16 variants in vulvar dysplastic or neoplastic biopsies.
    Tan SE, Garland SM, Rumbold AR, Zardawi I, Taylor-Thomson D, Condon JR, Tabrizi SN.
    Sex Health; 2013 Mar 29; 10(1):18-25. PubMed ID: 23158206
    [Abstract] [Full Text] [Related]

  • 10. Infection of human papillomaviruses in cancers of different human organ sites.
    Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, Das BC.
    Indian J Med Res; 2009 Sep 29; 130(3):222-33. PubMed ID: 19901431
    [Abstract] [Full Text] [Related]

  • 11. Frequent association of human papillomavirus 16 and 18 DNA with anal squamous cell and basaloid carcinoma.
    Vincent-Salomon A, de la Rochefordière A, Salmon R, Validire P, Zafrani B, Sastre-Garau X.
    Mod Pathol; 1996 Jun 29; 9(6):614-20. PubMed ID: 8782197
    [Abstract] [Full Text] [Related]

  • 12. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer.
    Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V.
    Obstet Gynecol; 2006 Dec 29; 108(6):1361-8. PubMed ID: 17138767
    [Abstract] [Full Text] [Related]

  • 13. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Lindquist S, Frederiksen K, Petersen LK, Kjær SK.
    Int J Cancer; 2024 Jul 01; 155(1):61-70. PubMed ID: 38418719
    [Abstract] [Full Text] [Related]

  • 14. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E, Largeron N.
    J Med Econ; 2013 Jul 01; 16(6):763-76. PubMed ID: 23565814
    [Abstract] [Full Text] [Related]

  • 15. Five-year relative survival for human papillomavirus-associated cancer sites.
    Razzaghi H, Saraiya M, Thompson TD, Henley SJ, Viens L, Wilson R.
    Cancer; 2018 Jan 01; 124(1):203-211. PubMed ID: 29105738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas.
    Huang FY, Kwok YK, Lau ET, Tang MH, Ng TY, Ngan HY.
    Cancer Genet Cytogenet; 2005 Feb 01; 157(1):42-8. PubMed ID: 15676146
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Mpunga T, Chantal Umulisa M, Tenet V, Rugwizangoga B, Milner DA, Munyanshongore C, Heideman DAM, Bleeker MCG, Tommasino M, Franceschi S, Baussano I, Gheit T, Sayinzoga F, Clifford GM.
    Int J Cancer; 2020 Mar 15; 146(6):1514-1522. PubMed ID: 31173641
    [Abstract] [Full Text] [Related]

  • 20. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A, Ahmed F, Saraiya M, Kosary C, Schwenn M, Cokkinides V, Flowers L, Pollack LA.
    Cancer; 2008 Nov 15; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.